Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa (Q72300240)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 June 1995

Language	Label	Description	Also known as
English	Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa	scientific article published on 01 June 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

A Corbet

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J Gerdes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

W Long

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

E Avila

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

A Puri

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

A Rosenberg

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Edwards

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

L Cook

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

126

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

969-978

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Lung function in prematurely delivered rabbits treated with a synthetic surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Prophylactic treatment of very premature infants with human surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Pulmonary surfactant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Clinical trials of natural surfactant extract in respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Clinical trials of synthetic surfactant in the respiratory distress syndrome of premature infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Effects of a clinically detectable PDA on pulmonary mechanics measures in VLBW infants with RDS

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970226-1

7 January 2021

Identifiers

10.1016/S0022-3476(95)70226-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7776110%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72300240&oldid=1756387632"